Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study
(1) Background: Favipiravir (FVP) is a new antiviral drug used to treat COVID-19. It has been authorized to be used in the kingdom of Saudi Arabia in the treatment of COVID-19. The mechanism of action of FVP is working as a specific inhibitor for the RNA-dependent RNA polymerase of the RNA chain vir...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2023-02-01
|
| Edice: | Tropical Medicine and Infectious Disease |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2414-6366/8/2/129 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|